menu
    • menu

    Company profile for Adlai Nortye

    NEW Drugs in Dev: 7
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adlai Nortye is a science-led biopharmaceutical company dedicated to discovering, developing and commercializing new drugs in the field of oncology/immuno-oncology. Our mission is to improve patient lives by developing differentiated, innovative medicines that help people live better and longer. We have 23 patents granted and 7 PCT published. With extensive experience in peptide and protein drugs, we have expanded our expertis...
    Adlai Nortye is a science-led biopharmaceutical company dedicated to discovering, developing and commercializing new drugs in the field of oncology/immuno-oncology. Our mission is to improve patient lives by developing differentiated, innovative medicines that help people live better and longer. We have 23 patents granted and 7 PCT published. With extensive experience in peptide and protein drugs, we have expanded our expertise into small molecules and therapeutic antibodies. Through close collaboration with global partners, we have successfully positioned ourselves in the fields of immuno-oncology/oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adlai NortyeChina Flag
    Country
    Country
    China
    Address
    Address
    21 Floor, Building No.2, No.452, 6th street, Hangzhou Economic & Technological...
    Telephone
    Telephone
    0571-28918366
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.adlainortye.com/en.php
    Linkedin
    Linkedin
    https://in.linkedin.com/company/%E6%9D%AD%E5%B7%9E%E9%98%BF%E8%AF%BA%E7%94%9F%E7%89%A9%E5%8C%BB%E8%8D%AF%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adlai Nortye Enrolls First Patient in Pan-RAS Ph 1 Trial
    Adlai Nortye Enrolls First Patient in Pan-RAS Ph 1 Trial

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3236924/0/en/Adlai-Nortye-Announces-First-Patient-Enrolled-in-Global-Phase-1-Trial-of-Pan-RAS-ON-Inhibitor-AN9025-for-Solid-Tumors-Harboring-RAS-Mutations.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Adlai Nortye Reveals $140M Private Placement Equity Financing
    Adlai Nortye Reveals $140M Private Placement Equity Financing

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230907/0/en/Adlai-Nortye-Announces-140-0-Million-Private-Placement-Equity-Financing.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Adlai Nortye Secures Exclusive License For Pan-Ras Inhibitor
    Adlai Nortye Secures Exclusive License For Pan-Ras Inhibitor

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210832/0/en/Adlai-Nortye-Enters-Exclusive-License-Agreement-with-ASK-Pharm-for-Pan-RAS-ON-Inhibitor-AN9025-in-Greater-China.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Adlai Nortye To Participate In Upcoming Investor Conferences
    Adlai Nortye To Participate In Upcoming Investor Conferences

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192755/0/en/Adlai-Nortye-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    Adlai Nortye To Present AN4035 Preclinical Results
    Adlai Nortye To Present AN4035 Preclinical Results

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170782/0/en/Adlai-Nortye-to-Present-Short-Talk-on-AN4035-Preclinical-Results-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Adlai Nortye to Present Research at AACR Annual Meeting 2025
    Adlai Nortye to Present Research at AACR Annual Meeting 2025

    10 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/10/3059197/0/en/Adlai-Nortye-to-Present-Research-Findings-at-AACR-Annual-Meeting-2025.html

    GLOBENEWSWIRE
    10 Apr 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search